Precision Medicine in GI Cancers: Targeting the DNA Damage Response and Repair Pathway

Part of the Surgical Grand Rounds Series - Michael Pishvaian, MD, PhD explains how to evaluate the frequency of actionable molecular alternations in GI cancers. He also reviews current data of targeted therapy for biomarker-selected patients with advanced GI cancers. Dr. Pishvaian identifies the potential for targeting DNA damage response and repair for the treatment of advanced pancreatic cancer. 


Created by

Johns Hopkins Greater Washington Area